These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


649 related items for PubMed ID: 16530441

  • 1. Specimen processing time and measurement of total insulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3 (IGFBP-3).
    Harris TG, Strickler HD, Yu H, Pollak MN, Monrad ES, Travin MI, Xue X, Rohan TE, Kaplan RC.
    Growth Horm IGF Res; 2006 Apr; 16(2):86-92. PubMed ID: 16530441
    [Abstract] [Full Text] [Related]

  • 2. Serum levels of insulin-like growth factor-I and insulin-like growth factor-I binding protein-3: quality control for studies of stored serum.
    Berrigan D, Potischman N, Dodd KW, Nicar M, McQuillan G, Lavigne JA, Barrett JC, Ballard-Barbash R.
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1017-22. PubMed ID: 17507631
    [Abstract] [Full Text] [Related]

  • 3. Measurement of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 after delayed separation of whole blood samples.
    Hartog H, van der Graaf WT, Wesseling J, van der Veer E, Boezen HM.
    Clin Biochem; 2008 May; 41(7-8):636-9. PubMed ID: 18294961
    [Abstract] [Full Text] [Related]

  • 4. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM, van Doorn J, Stijnen T, Drop SL, de Muinck Keizer-Schrama SM.
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [Abstract] [Full Text] [Related]

  • 5. Insulin-like growth factors and prostate cancer: a population-based case-control study in China.
    Chokkalingam AP, Pollak M, Fillmore CM, Gao YT, Stanczyk FZ, Deng J, Sesterhenn IA, Mostofi FK, Fears TR, Madigan MP, Ziegler RG, Fraumeni JF, Hsing AW.
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):421-7. PubMed ID: 11352850
    [Abstract] [Full Text] [Related]

  • 6. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
    Heald A, Kaushal K, Anderson S, Redpath M, Durrington PN, Selby PL, Gibson MJ.
    Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
    [Abstract] [Full Text] [Related]

  • 7. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.
    Johansson H, Baglietto L, Guerrieri-Gonzaga A, Bonanni B, Mariette F, Macis D, Serrano D, Sandri MT, Decensi A.
    Breast Cancer Res Treat; 2004 Nov; 88(1):63-73. PubMed ID: 15538047
    [Abstract] [Full Text] [Related]

  • 8. Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin.
    Chen C, Lewis SK, Voigt L, Fitzpatrick A, Plymate SR, Weiss NS.
    Cancer; 2005 Jan 01; 103(1):76-84. PubMed ID: 15540247
    [Abstract] [Full Text] [Related]

  • 9. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.
    Spitz MR, Barnett MJ, Goodman GE, Thornquist MD, Wu X, Pollak M.
    Cancer Epidemiol Biomarkers Prev; 2002 Nov 01; 11(11):1413-8. PubMed ID: 12433720
    [Abstract] [Full Text] [Related]

  • 10. Stability of insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-3 measured by the IMMULITE automated chemiluminescence assay system in different blood specimens.
    Elmlinger MW, Zwirner M, Kühnel W.
    Clin Lab; 2005 Nov 01; 51(3-4):145-52. PubMed ID: 15819169
    [Abstract] [Full Text] [Related]

  • 11. Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.
    Woodson K, Tangrea JA, Pollak M, Copeland TD, Taylor PR, Virtamo J, Albanes D.
    Cancer Res; 2003 Jul 15; 63(14):3991-4. PubMed ID: 12873996
    [Abstract] [Full Text] [Related]

  • 12. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
    Schernhammer ES, Holly JM, Hunter DJ, Pollak MN, Hankinson SE.
    Endocr Relat Cancer; 2006 Jun 15; 13(2):583-92. PubMed ID: 16728584
    [Abstract] [Full Text] [Related]

  • 13. Inverse correlation between serum free IGF-I and IGFBP-3 levels and blood pressure in patients affected with type 1 diabetes.
    Capoluongo E, Pitocco D, Lulli P, Minucci A, Santonocito C, Manto A, Di Stasio E, Zaccardi F, Zuppi C, Ghirlanda G, Ameglio F.
    Cytokine; 2006 Jun 15; 34(5-6):303-11. PubMed ID: 16887362
    [Abstract] [Full Text] [Related]

  • 14. Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays.
    Rinaldi S, Kaaks R, Zeleniuch-Jacquotte A, Arslan AA, Shore RE, Koenig KL, Dossus L, Riboli E, Stattin P, Lukanova A, Toniolo P.
    Cancer Epidemiol Biomarkers Prev; 2005 Jan 15; 14(1):48-52. PubMed ID: 15668475
    [Abstract] [Full Text] [Related]

  • 15. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps.
    Schoen RE, Weissfeld JL, Kuller LH, Thaete FL, Evans RW, Hayes RB, Rosen CJ.
    Gastroenterology; 2005 Aug 15; 129(2):464-75. PubMed ID: 16083703
    [Abstract] [Full Text] [Related]

  • 16. Relationship between umbilical cord blood insulin-like growth factors and anthropometry in term newborns.
    Hung TY, Lin CC, Hwang YS, Lin SJ, Chou YY, Tsai WH.
    Acta Paediatr Taiwan; 2008 Aug 15; 49(1):19-23. PubMed ID: 18581724
    [Abstract] [Full Text] [Related]

  • 17. Insulin-like growth factor-I and its binding proteins in colostrum compared to measures in serum of Holstein neonates.
    Sparks AL, Kirkpatrick JG, Chamberlain CS, Waldner D, Spicer LJ.
    J Dairy Sci; 2003 Jun 15; 86(6):2022-9. PubMed ID: 12836938
    [Abstract] [Full Text] [Related]

  • 18. Effect of raloxifene on insulin-like growth factor-I, insulin-like growth factor binding protein-3, and leptin in premenopausal women at high risk for developing breast cancer.
    Eng-Wong J, Hursting SD, Venzon D, Perkins SN, Zujewski JA.
    Cancer Epidemiol Biomarkers Prev; 2003 Dec 15; 12(12):1468-73. PubMed ID: 14693739
    [Abstract] [Full Text] [Related]

  • 19. Total insulinlike growth factor 1 and insulinlike growth factor binding protein levels, functional status, and mortality in older adults.
    Kaplan RC, McGinn AP, Pollak MN, Kuller L, Strickler HD, Rohan TE, Xue X, Kritchevsky SB, Newman AB, Psaty BM.
    J Am Geriatr Soc; 2008 Apr 15; 56(4):652-60. PubMed ID: 18312313
    [Abstract] [Full Text] [Related]

  • 20. Effects of pure ethanol and alcopops on glucose, insulin, and the insulin-like growth factor system in healthy subjects.
    Grønbaek H, Flyvbjerg A, Winding P, Frystyk J, Hey H.
    Growth Horm IGF Res; 2005 Aug 15; 15(4):243-50. PubMed ID: 15925526
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 33.